RARRES2 and preeclampsia: They proposed chemerin as an independent risk factor of preeclampsia, with the estimated sensitivity of 87.8% and specificity of 75.7%, in the prediction of preeclampsia (threshold value > 183.5 ng/mL, estimated AUC—0.85) [197].